Abstract
The authors report the sequence of the clinical symptoms in type I sialidosis or cherry-red spot myoclonus syndrome, derived from the cases personally observed and from the literature. They also report neuropathological and neurochemical data. A serial EEG study in a case shows the tendency to a progressive deregulation of cerebral electric activity. Therapeutic attempts to reduce myoclonus, which is one of the more disabling symptoms in this syndrome, are described.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adolescent
-
Adult
-
Anticonvulsants / therapeutic use
-
Brain / pathology
-
Child
-
Electroencephalography
-
Epilepsies, Myoclonic / drug therapy
-
Epilepsies, Myoclonic / etiology*
-
Epilepsies, Myoclonic / pathology
-
Fundus Oculi*
-
Humans
-
Liver / pathology
-
Lysosomal Storage Diseases* / complications
-
Lysosomal Storage Diseases* / enzymology
-
Lysosomal Storage Diseases* / pathology
-
Lysosomal Storage Diseases* / urine
-
Neuraminidase / deficiency*
-
Oligosaccharides / urine
-
Syndrome
Substances
-
Anticonvulsants
-
Oligosaccharides
-
sialooligosaccharides
-
Neuraminidase